For sales

Highlights from the Week of 14th Sep – 21st Sep in the world of pharma and healthcare!

Highlights from the week of 14th Sep - 21st Sep Alfasigma ( CHMP, Positive Opinion ) CHMP issues positive opinion for Alfasigma's filgotinib to treat axSpA in patients with an inadequate response to conventional therapy Novo Nordisk ( CHMP, Positive Opinion ) Novo Nordisk gets positive CHMP opinion for SOGROYA, administered once weekly, for children with ISS and persistent growth disturbances AstraZeneca ( CHMP, Positive Opinion ) CHMP recommends positive opinion to AstraZeneca's ENHERTU as a monotherapy for the adjuvant treatment of adults with resected HER2-positive breast cancer Roche ( CHMP, Positive Opinion ) Roche gains a positive CHMP opinion for its OCREVUS IV infusion to treat patients aged 10 years and older with RMS All logos and trademarks remain the intellectual properties of their respective owners
Download

Connect with us

Please fill in the information below, and we'll get back to you.